Performance characteristics of 7-aminoflunitrazepam specific enzyme-linked immunosorbent assays

Journal of Analytical Toxicology

Volumn 29, Issue 7, 2005, Pages 718-723

  Lin, Dong Liang ^a   Yin, Rea Ming ^a   Chen, Cheng Hsing ^b   Chen, Ya Lei ^c   Liu, Ray H ^d  

^a Ministry of Justice   (Taiwan)

^b Ping An Hospital   (Taiwan)

^c NATIONAL KAOHSIUNG NORMAL UNIVERSITY   (Taiwan)

^d FOOYIN UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

7 AMINOFLUNITRAZEPAM; BENZODIAZEPINE; DIAZEPAM; FLUNITRAZEPAM; REAGENT;

ACCURACY; ARTICLE; CHEMICAL ANALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; CROSS REACTION; DILUTION; DRUG DETERMINATION; DRUG PROGRAM; ENZYME LINKED IMMUNOSORBENT ASSAY; GAS CHROMATOGRAPHY; HUMAN; IMMUNOASSAY; MASS SPECTROMETRY; SENSITIVITY AND SPECIFICITY; URINALYSIS;

EID: 29144528854     PISSN: 01464760     EISSN: 01464760     Source Type: Journal    
DOI: 10.1093/jat/29.7.718     Document Type: Article

References (10)

1. D. Anglin, K.L. Spears, and H.R. Hutson. Flunitrazepam and its involvement in date or acquaintance rape. Acad. Emerg. Med. 4: 323-326 (1997).
2. M.A. ElSohly and S.J. Salamone. Prevalence of drugs used in cases of alleged sexual assault. J. Anal. Toxicol. 23: 141-146 (1999).
3. O.H. Drummer. Benzodiazepines-effects on human behavior and performance. Forensic Sci. Rev. 14: 1-14 (2002).
4. A.M. Barrett, K. Walshe, P. V. Kavanagh, S.M. McNamara, C. Moran, J. Burdett, and A.G. Shattock. A comparison of five commercial immunoassays for the detection of flunitrazepam and other benzodiazepines in urine. Addict. Biol. 4: 81-87 (1999).
5. P.H. Wang, C. Liu, W.I. Ts a y, J.H. Li, R.H. Liu, T.G. Wu, W.J. Cheng, D.L. Lin, T.Y. Huang, and C.H. Chen. Improved screen and confirmation test of 7-aminoflunitrazepam in urine specimens for monitoring flunitrazepam (Rohypnol) exposure. J. Anal. Toxicol. 26: 411-418 (2002).
6. S.J. Salamone, S. Honasoge, C. Brenner, A.J. McNally, J. Passarelli, K. Goc-Szkutnicka, R. Brenneisen, M.J. ElSohly, and S. Feng. Flunitrazepam excretion patterns using the Abuscreen OnTrak and OnLine immunoassays: comparison with GC-MS. J. Anal. Toxicol. 21: 341-345 (1997).
7. H. Snyder, K.S. Schwenzer, R. Pearlman, A.J. McNally, M. Tsilimidos, S.J. Salamone, R. Brenneisen, M.A. ElSohly, and S. Feng. Serum and urine concentrations of flunitrazepam and metabolites, after a single oral dose, by immunoassay and GC-MS. J. Anal. Toxicol. 25: 699-704 (2001).
8. Z. Lin and O. Beck. Procedure for verification of flunitrazepam and nitrazepam intake by gas chromatographic-mass spectrometric analysis of urine. J. Pharm. Biomed. Anal. 13: 719-722 (1995).
9. M.A. ElSohly, S. Feng, S.J. Salamone, and R. Wu. A sensitive GC-MS procedure for the analysis of flunitrazepam and its metabolites in urine. J. Anal. Toxicol. 21: 335-340 (1997).
10. A. Negrusz, C.M. Moore, T.L. Stockham, K.R. Poiser, J.L. Kern, R. Palaparthy, N.L. Le, P.G. Janicak, and N.A. Levy. Elimination of 7-aminoflunitrazepam and flunitrazepam in urine after a single dose of Rohypnol. J. Forensic Sci. 45: 1031-1040 (2000).